Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s12072-010-9163-9
| Title: | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Authors: | Ahn, S.H. Chan, H.L.Y. Chen, P.-J. Cheng, J. Goenka, M.K. Hou, J. Lim, S.G. Omata, M. Piratvisuth, T. Xie, Q. Yim, H.J. Yuen, M.-F. |
Keywords: | ALT Chronic hepatitis B (CHB) HBV DNA Hepatitis B virus (HBV) Interferon alfa Nucleoside/nucleotide analog |
Issue Date: | 2010 | Citation: | Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F. (2010). Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions. Hepatology International 4 (1) : 386-395. ScholarBank@NUS Repository. https://doi.org/10.1007/s12072-010-9163-9 | Source Title: | Hepatology International | URI: | http://scholarbank.nus.edu.sg/handle/10635/26950 | ISSN: | 19360533 19360541 |
DOI: | 10.1007/s12072-010-9163-9 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.